Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

On November 4, Nobel laureate Joseph Stiglitz handed President Cyril Ramaphosa the world’s first G20 Inequality Report, ...

The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...

He is regularly dubbed the world's best ever diver, but Olympic gold medallist Greg Louganis still questions whether he missed out on lucrative sponsorship deals and top TV jobs because he was gay and ...

A seven-year-old thalassemia patient in Jharkhand has tested HIV-positive, leading to an investigation into allegations of contaminated blood transfusion from the local blood bank. A five-member team ...

(The Center Square) - A Washington State Economic and Revenue Forecast Council report found that the states commercial real estate excise tax revenue has fallen to pre-2020 levels before the ...

CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...

DUBLIN--(BUSINESS WIRE)--The "HIV Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for HIV Drugs was valued at US$32.8 Billion in ...

Throughout her career, AEW star Mercedes Mone has been offered several roles in television, film and commercials due to her popularity in the wrestling business. The TBS Champion has worked on ...